Trademarkia Logo

Canada

C$
TEVA LOGO COLOUR
REGISTERED

on 24 Jan 2020

Last Applicant/ Owned by

TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 Dvora HaNevi'a6944020 Tel Aviv-Jaffa

IL

Serial Number

1769000 filed on 23rd Feb 2016

Registration Number

TMA1070732 registered on 24th Jan 2020

Registration expiry Date

24th Jan 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

TEVA LOGO COLOUR

Trademark usage description

chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pha Read More

Vienna Information


25 . 5 . 5

Backgrounds divided crosswise, vertically and horizontallyFonds partagés en croix dans le sens vertical et le sens horizontal

25 . 5 . 6

Backgrounds divided crosswise, diagonallyFonds partagés en croix en diagonale

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 11

Letters or numerals representing a plantLettres ou chiffres représentant un végétal

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information


Class [001]
Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations.


Classification kind code

10

Class [003]
Bleaching preparations and detergents for laundry use; cleaning, polishing, scouring and abrasive preparations for cleaning medical instruments; soaps, namely, anti-bacterial soaps, disinfectant soaps and industrial soaps; perfumery; cosmetics; hair lotions; dentifrices.


Classification kind code

10

Class [005]
Pharmaceutical preparations, prescription and over-the-counter, namely, acne medications, allergy medications, alopecia medications, anabolics, analgesics, anesthetics, antacids, anorectics, anthelmintics, antianaemics, anti-anaemia drugs, antianginals, antiarrhythmics, antibacterials, antibiotics, antibiotic creams and ointments, anticoagulants, anticonvulsants, antidepressants, antidiabetics, antidiarrhoeals, antidotes to counteract opioids and to treat overdoses of folic acid antagonists and iron overloading; antiemetics, anti-arthritis medications, anti-epileptics, antifibrinolytics, antiflatulents, antifungals, antigout medications, antihistamines, antihypertensives, anti-infectives, anti-inflammatories, antileprotics, antimalarials, anti-obesity medications, antiparasites, anti-parkinsonians, antipsoriasis medications, antipyretics, antirheumatic medications, anti-sickling medications, anti-smoking agents, antispasmodics, antithrombotics, antitussive medications, antiulcer medications, antivirals, appetite stimulants, appetite suppressants, asthma medications, autonomic agents, beta blockers, bone metabolism regulators, bronchodilators, burn relief medications, calcium channel blockers, calcium metabolism regulators, cancer and antineoplastic medications, central nervous system depressants, central nervous system stimulants, cough medications, cardioglycoside, cardiostimulents, cardiovascular drugs, cholagogues, cholesterol lowering agents, contraceptive medications, corticosteroids, gastro-intestinal medications, diuretics, fibrinolytics, emollients, expectorants, gastro-intestinal medications, gastroprokinetics, glaucoma medications, haemostatics, haemotological medications, hepatoprotectors, hormonal medications for use in hormone replacement therapy and in the treatment of cancer; human growth hormones; hydrocortisone, hypolipaemics, hypnotic agents, immunoglobulins, immunomodulators, immunosuppressants, impotence and sexual dysfunction medications, incontinence medications, infertility drugs, insomnia medications, insulin, iron, laxatives, liver extract, migraine medications, medications for balancing electrolytic, caloric and water levels, medications for preventing and treating sequelae of oncologic diseases and their treatment, namely, nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain and fatigue, medications for treating dermatological diseases and disorders, namely, dermatitis, skin and skin structure diseases, infections and injuries, psoriasis, eczema and sexually transmitted diseases, medications for treating ocular motility disorders, medications for treating neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, medications for treating obesity and weight loss and for weight management, medications for treating psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses, medications for treating renal and cardio-renal diseases, medications for preventing and treating respiratory diseases and their symptoms, medications for treating sexually transmitted diseases, mineral supplements, muscular dystrophy medications, mucolytics, muscle relaxants, multiple sclerosis medications, narcotic agents, narcotic antagonists, nasal decongestants, neuroleptics, non-steroidal anti-inflammatory drugs (NSAIDS), opiods, opthalmological drugs, otological drugs, osteoporosis medications, plasma substitutes and blood fractions, plasmodicides, psychotherapeutic and psychotropic agents, restless leg medications, sedatives, tuberculostatics, vasodilators, vasoprotective medications, vitamins, vulnerary medications, human vaccines.


Classification kind code

10

Class [009]
Downloadable software in the nature of mobile applications, computer application software and computer software, all for use in medical diagnosis, namely to assist doctors with making differential diagnoses, in medical imaging, for providing educational information and instruction in healthcare, pharmaceuticals and pharmacy, and for managing patient care and patient records.


Classification kind code

10

Class [010]
Surgical instruments; dental instruments; veterinary instruments.


Classification kind code

10

Class [016]
Printed publications, namely, books, hand-outs, workbooks, and journals, featuring information regarding allergies, the treatment thereof, and patient services for allergies.


Classification kind code

10

Class [035]
Management of business affairs and commercial functions of an enterprise in the pharmaceutical industry, namely personnel recruitment, personnel management consultancy and accounting services, business research relating to the development of new products and business opportunities, and marketing research.


Classification kind code

10

Class [042]
Research services in the field of pharmaceuticals; consulting services pertaining to pharmacology.


Classification kind code

10

Mark Details


Serial Number

1769000

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 27th Dec 2017
Advertised
Submitted for opposition 26
on 7th Dec 2017
Approved
Submitted for opposition 27
on 19th Oct 2017
Approval Notice Sent
Submitted for opposition 15
on 24th Aug 2017
Correspondence Created
Submitted for opposition 15
on 15th Mar 2017
Correspondence Created
Submitted for opposition 22
on 14th Nov 2016
Search Recorded
Submitted for opposition 20
on 14th Nov 2016
Examiner's First Report
Submitted for opposition 31
on 29th Feb 2016
Formalized
Submitted for opposition 30
on 23rd Feb 2016
Filed
Submitted for opposition 1
on 23rd Feb 2016
Created